PATENT CLAIM ANALYSIS

Application Number: 16057335
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "220000"]

Abstract:
Provided are methods of administering glycerol phenylbutyrate to a patient in need thereof, wherein said patient is also being treated with a CYP3A4 substrate having a narrow therapeutic index, midazolam or a pharmaceutically acceptable salt thereof, or celecoxib.

Claim (Index 34):
The method of  claim 21 , further comprising administering an increased dosage of the alfentanil or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12350111', '12784738', '12272873', '13271830', '13224589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7297551869608211
- 35 USC 102 Novelty (BERT): 0.5076703778574164
- Combined Prediction Score: 0.7075467060504806
- Mean Citation Score: 210.76274
- Max Citation Score: 221.66754
- Similarity Product: 138.0785888583541

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test